Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Eric Pujade-Lauraine, MD, PhD, Hôpital Hôtel-Dieu, Paris, France, outlines approaches to improve outcomes in patients with ovarian cancer treated with immune checkpoint inhibitors, including combinations with chemotherapy as well as bevacizumab. This interview took place at the European Society of Gynaecological Oncology (ESGO) 2021 congress in Prague.